The University College's Royal Free Hospital in London, UK, which lastyear declared that there may be a link between the combined measles-mumps-rubella vaccine and a syndrome characterized by autism and inflammatory bowel disease (Marketletter March 16, 1998), have found in a new study that the rate of autism is no higher among children inoculated with the vaccine than those who do not receive the shot.
A different group of researchers at the hospital, who identified 498 children with autism from government health registers, found no evidence to support a connection with the MMR vaccine. While the study showed the number of cases of autism has been increasing since 1979, there was no sign of a sharp rise following introduction of the vaccine in 1988.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze